Best Small Giants Academy Podcasts (2025)

1
Mindfulness in the digital age with Thupten Jinpa 47:44

Play Pause

3h ago47:44

47:44

In this episode Berry sits down with Thupten Jinpa, longtime translator and companion to His Holiness the Dalai Lama, for a conversation about compassion, transformation, and what it means to live a spiritual life in the modern world. Jinpa shares his extraordinary journey of monkhood, lessons he learnt from the Dalai Lama, and muses on profound te…

1
50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia 4:24

11h ago4:24

4:24

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about how monoclonal antibodies revolutionized neurologic treatment, why pregabalin link to increased heart failure, and a combined therapy that slows progression in primary progressive aphasia.By American Academy of Neurology

1
Novel PET radiotracer, GLP-1s and dementia risk, green space benefits 4:49

24d ago4:49

4:49

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a PET radiotracer that shows intranasally delivered insulin enters the brain, GLP-1s and dementia risk in people with Type 2 diabetes, and how exposure to green space may reduce the risk of neurodevelopmental delays in children.…

1
Pegivirus' role in Parkinson's disease, GLP-1s and idiopathic intracranial hypertension, geographic spread of epilepsy specialists 4:59

1M ago4:59

4:59

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about pegivirus's potential role in Parkinson's disease pathology, the impact of GLP-1 receptor agonistst on idiopathic intracranial hypertension, and the geographic spread of epilepsy specialists.By American Academy of Neurology

1
Food deserts and stroke risk, physical activity in Parkinson's disease, rimegepant for migraine 4:51

2M ago4:51

4:51

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the relationship between income, "food deserts," and stroke risk; why staying active may reduce cognitive decline in patients with Parkinson's disease; and how initiating rimegepant for migraine could help reduce opioid and butalbital use.…

1
Parkinson's and dementia with Lewy bodies blood test, CAR T-cell therapy for glioblastoma, wireless EEG 4:27

2M ago4:27

4:27

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a promising blood test to distinguish Parkinson's disease from dementia with Lewy bodies, how CAR T-cell therapies are showing potential for patients with glioblastoma, and a new wireless electroencephalogram device that can even monitor young children with epil…

1
Matt Kuperholz on the ethics of AI 52:15

3M ago52:15

52:15

In this episode, Berry sits down with Matt Kuperholz —a seasoned computer scientist, business advisor, and creative mind with over 30 years’ experience bringing AI solutions to life. Matt isn’t just tech-savvy—he’s an AI optimist who’s been living and breathing technology since childhood. This sprawling, exploratory conversation is perfect for list…

1
Small fiber neuropathy, Dr. Merit Cudkowicz, work-life balance for families of neurologists 3:52

3M ago3:52

3:52

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about whether small fiber neuropathy is an autoimmune disorder; Merit Cudkowicz, MD, MSc, FAAN, recipient of this year's AAN Lifetime Achievement Award for Clinically Relevant Research; and how neurologist couples pursue work-life balance.…

1
Sam Lee on songkeeping and the sacred 37:21

3M ago37:21

37:21

In this episode of the Wisdom and Action podcast, Berry sits down with Sam Lee, the acclaimed British folk singer, song collector, and environmental activist. Sam shares his remarkable journey from apprentice song collector to national treasure, revealing how ancient music, oral tradition, and nature are deeply intertwined. The conversation flows f…

1
Divisive treatment for cluster headache, head positioning before thrombectomy, new series, "Neurology in America" 4:10

3M ago4:10

4:10

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about eptinezumab, a treatment for episodic cluster headache; how positioning the head flat before a thrombectomy benefited patients with large vessel occlusion stroke; and what rural neurology looks like in 2025, the first story in our new series, Neurology in Americ…

1
The Red School on reclaiming cycles 44:00

4M ago44:00

44:00

In this episode, Berry welcomes Sjane and Alexandra—co-founders of Red School and pioneers in menstruality education—for a conversation that invites us to rethink our relationship with the rhythms of our bodies and lives. Sjane and Alexandra bring profound insight and warmth to questions rarely asked: How can we reclaim the power of our cycles? Wha…

1
New treatment for giant-cell arteritis, links between oral and brain health, an emerging meningitis B vaccine 4:34

4M ago4:34

4:34

In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about upadacitinib, a new treatment for giant-cell arteritis; growing evidence linking oral health to a higher risk of neurologic conditions; and why a trial of a new meningitis B vaccine drew a mixed response.By American Academy of Neurology

1
Kaj Löfgren on fostering community 47:09

4M ago47:09

47:09

Kaj Löfgren has spent his life building movements, nurturing communities, and turning bold ideas into reality. Kaj is a social innovator, systems thinker, founding force behind the School of Life Australia, Regen Melbourne, and is also the Head of Small Giants Labs and member of the Small Giants Founders Circle. In this episode he brings a unique p…

1
Telomere length and and risk for neurologic disorders, impact of research cuts on promotion/tenure, herpes zoster vaccine and dementia 4:51

5M ago4:51

4:51

In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles on the association of shortened telomeres on risk for stroke, late-life depression and dementia; affect of research funding cuts on tenure/promotion opportunities; and herpes zoster vaccine and reduced dementia risk.By American Academy of Neurology

1
Indy Johar on entangled wisdom 39:36

5M ago39:36

39:36

What happens when you sit down with someone who’s spent their life not just designing buildings, but reimagining the very systems that shape our world? In this episode, Berry welcomes Indy Johar—architect, philosopher, and co-founder of Dark Matter Labs—for a conversation that dives deep into the heart of what it means to live wisely and act boldly…

1
Post-TIA fatigue, neurologic complications of measles, CDC surveillance of epilepsy program dismantled. 4:14

5M ago4:14

4:14

In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles studies showing persistent fatigue after TIA, the neurologic complications of measles, and the impact of the dismantling of a CDC surveillance program of epilepsy.By American Academy of Neurology

1
Sandrine Dixson-Declève on change for good 40:06

5M ago40:06

40:06

What happens when you sit down with someone who’s spent their life building bridges—across continents, industries, and even generations? In this episode, Berry welcomes Sandrine Dixon-Declève, co-president of the Club of Rome, for a candid conversation about hope, courage, and finding wisdom in the chaos of our times. Sandrine brings warmth, honest…

1
Advances in cell therapies for Parkinson's, GLP-1 agonists and dementia risk, FDA accelerated approvals for neurology drugs 4:14

6M ago4:14

4:14

In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about early studies finding dopamine cellular therapies were safe and tolerable for patients with Parkinson's, use of GLP-1 agonists were associated with reduced dementia risks, and the FDA use of accelerated approvals for several neurology drugs are under scrutiny.…

1
Microplastics in brain, salary gap in neurology, the neurology of space 4:16

7M ago4:16

4:16

In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles finding microplastics in the brain postmortem linked to dementia, the salary gap between men and women neurologies, and neurologists studying the impact of microgravity on the brain.By American Academy of Neurology

1
Impact of high-dose Vitamin D on MS relapse, the role of AI in neurology education, and a 4D animal model that shows precursors of MS lesions before they appear. 4:41

7M ago4:41

4:41

In this episodeof Neurology Today in 5, Neurology Today editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a large trial that found high-dose Vitamin D reduced MRI evidence of disease activity in patients with clinically isolated syndrome or early relapsing MS; an animal brain map, revealing changes in inflammation, immune activity, and cell re…

1
New approved drug for neurofibromatosis 1 with plexiform neurofibromas, multidisciplinary clinics in neurology, impact of cuts to DEI research grants 4:35

8M ago4:35

4:35

In this week's podcast, Neurology Today's editor-in-chief highlights articles on the newly approved drug for neurofibromatosis 1 with plexiform neuromas in adults, how neurology practices are integrating with multiple subspecialties, and the impact of federal cuts to DEI grants and research.By American Academy of Neurology

1
Impact of NIH cuts on neurology research, response to ACP's guideline on migraine, an updated position on seizures, driver licensure, and medical reporting 5:06

8M ago5:06

5:06

In this week's podcast, Neurology Today's editor-in-chief highlights articles on the impact of NIH cuts to indirect research costs, response to a new guideline on migraine prevention from ACP, and an updated position statement from the AAN on seizures, driver licensures, and medical reporting.By American Academy of Neurology

1
Lifetime burden of dementia, hidden features on EEGs for epilepsy detection, neurology-trained pharmacists 4:44

9M ago4:44

4:44

In this week's podcast, Neurology Today's editor-in-chief highlights articles on the larger lifetime burden of dementia than projected, an AI-fueled program that detects hidden features in EEGs for epilepsy detection, and neurology-trained pharmacists who are working with neurology departments.By American Academy of Neurology

1
IVF and MS relapse, community-based neurologists doing clinical research, and the loneliness protein implicated in brain function. 5:25

9M ago5:25

5:25

In this week's podcast, Neurology Today's editor-in-chief highlights articles on new data on IVF safety for women with MS, an elevated protein associated with loneliness, social isolation and brain function, and the role of community-based neurologists in drug development.By American Academy of Neurology

1
Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment 4:49

9M ago4:49

4:49

In this week's podcast, Neurology Today's editor-in-chief highlights articles on the pros and cons of virtual neurology education, the FDA approval of tirzepatide for obesity-related obstructive sleep apnea, and the promise of AI for glioma assessment.By American Academy of Neurology

1
Middle meningeal artery embolization and subdural hematoma, processed red meat and dementia risk, and editor picks for best neurology advances of 2024. 4:24

10M ago4:24

4:24

In this week's podcast, Neurology Today's editor-in-chief highlights articles on the safety of middle meningeal artery embolization for chronic subdural hematoma, the processed red meat and risk for dementia, and editors' picks for the best advances of 2024.By American Academy of Neurology

1
Magnesium sulfate for cerebral palsy, novel gene therapy for muscular dystrophies, chronic traumatic encephalitis and suicidality in retired NFL players. 4:59

11M ago4:59

4:59

In this week's podcast, Neurology Today's editor-in-chief highlights articles on the latest Cochrane review of magnesium sulfate to prevent cerebral palsy; a novel mRNA system for gene therapy for muscular dystrophies, and the perception of CTE and suicidality risk in retired NFL players.By American Academy of Neurology

1
Revised criteria for diagnosing MS, AI for alleviating administrative burden, neonatal neurocritical care as a growing subspecialty 5:20

11M ago5:20

5:20

In this week's podcast, Neurology Today's editor-in-chief highlights articles on proposed updated criteria for diagnosing MS before symptoms manifest, the use of large language models to address administrative burden with electronic medical records, and the growth of training programs in neonatal neurocritical care.…

Small Giants Academy Podcasts

5401
The Wisdom & Action Podcast

Small Giants Academy

1
Neurology Today in 5

American Academy of Neurology

1
Mindfulness in the digital age with Thupten Jinpa 47:44

1
50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia 4:24

1
Novel PET radiotracer, GLP-1s and dementia risk, green space benefits 4:49

1
Pegivirus' role in Parkinson's disease, GLP-1s and idiopathic intracranial hypertension, geographic spread of epilepsy specialists 4:59

1
Food deserts and stroke risk, physical activity in Parkinson's disease, rimegepant for migraine 4:51

1
Parkinson's and dementia with Lewy bodies blood test, CAR T-cell therapy for glioblastoma, wireless EEG 4:27

1
Matt Kuperholz on the ethics of AI 52:15

1
Small fiber neuropathy, Dr. Merit Cudkowicz, work-life balance for families of neurologists 3:52

1
Sam Lee on songkeeping and the sacred 37:21

1
Divisive treatment for cluster headache, head positioning before thrombectomy, new series, "Neurology in America" 4:10

1
The Red School on reclaiming cycles 44:00

1
New treatment for giant-cell arteritis, links between oral and brain health, an emerging meningitis B vaccine 4:34

1
Kaj Löfgren on fostering community 47:09

1
Telomere length and and risk for neurologic disorders, impact of research cuts on promotion/tenure, herpes zoster vaccine and dementia 4:51

1
Indy Johar on entangled wisdom 39:36

1
Post-TIA fatigue, neurologic complications of measles, CDC surveillance of epilepsy program dismantled. 4:14

1
Sandrine Dixson-Declève on change for good 40:06

1
Advances in cell therapies for Parkinson's, GLP-1 agonists and dementia risk, FDA accelerated approvals for neurology drugs 4:14

1
Microplastics in brain, salary gap in neurology, the neurology of space 4:16

1
Impact of high-dose Vitamin D on MS relapse, the role of AI in neurology education, and a 4D animal model that shows precursors of MS lesions before they appear. 4:41

1
New approved drug for neurofibromatosis 1 with plexiform neurofibromas, multidisciplinary clinics in neurology, impact of cuts to DEI research grants 4:35

1
Impact of NIH cuts on neurology research, response to ACP's guideline on migraine, an updated position on seizures, driver licensure, and medical reporting 5:06

1
Lifetime burden of dementia, hidden features on EEGs for epilepsy detection, neurology-trained pharmacists 4:44

1
IVF and MS relapse, community-based neurologists doing clinical research, and the loneliness protein implicated in brain function. 5:25

1
Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment 4:49

1
Middle meningeal artery embolization and subdural hematoma, processed red meat and dementia risk, and editor picks for best neurology advances of 2024. 4:24

1
Magnesium sulfate for cerebral palsy, novel gene therapy for muscular dystrophies, chronic traumatic encephalitis and suicidality in retired NFL players. 4:59

1
Revised criteria for diagnosing MS, AI for alleviating administrative burden, neonatal neurocritical care as a growing subspecialty 5:20